These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21915624)

  • 21. Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Sakimura K; Omori T; Iwashita E; Yoshida T; Tsuzuki Y; Fujimori K; Konishi F; Yoshida Y; Anzai H; Suzuki H; Sugawara S; Takeda Y; Hiraishi K; Saniabadi AR; Ide T; Miura S; Ota S
    Dig Dis Sci; 2006 Sep; 51(9):1525-31. PubMed ID: 16902810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis.
    Tanaka T; Okanobu H; Kuga Y; Yoshifuku Y; Fujino H; Miwata T; Moriya T; Nishida T; Oya T
    Gastroenterol Clin Biol; 2010 Dec; 34(12):687-95. PubMed ID: 20934287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.
    Yoshimura N; Yokoyama Y; Matsuoka K; Takahashi H; Iwakiri R; Yamamoto T; Nakagawa T; Fukuchi T; Motoya S; Kunisaki R; Kato S; Hirai F; Ishiguro Y; Tanida S; Hiraoka S; Mitsuyama K; Ishihara S; Tanaka S; Otaka M; Osada T; Kagaya T; Suzuki Y; Nakase H; Hanai H; Watanabe K; Kashiwagi N; Hibi T
    BMC Gastroenterol; 2015 Nov; 15():163. PubMed ID: 26585569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
    Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T
    Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes.
    Aoki H; Nakamura K; Yoshimatsu Y; Tsuda Y; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
    Dig Dis Sci; 2007 Jun; 52(6):1427-33. PubMed ID: 17394078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
    Fukunaga K; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Nagase K; Nakamura S; Miwa H; Matsumoto T
    J Clin Apher; 2011 Dec; 26(6):326-31. PubMed ID: 22083887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive granulocyte and monocyte adsorption versus intravenous prednisolone in patients with severe ulcerative colitis: an unblinded randomised multi-centre controlled study.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kageoka M; Ikeya K; Yamada M; Kikuyama M; Iwaoka Y; Hirayama K; Nagata S; Sato Y; Hosoda Y
    Dig Liver Dis; 2008 Jun; 40(6):433-40. PubMed ID: 18296130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study.
    Ueno N; Sugiyama Y; Kobayashi Y; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Takahashi K; Tanaka K; Serikawa S; Ando K; Kashima S; Muto M; Inaba Y; Moriichi K; Tanabe H; Okumura T; Fujiya M
    J Clin Apher; 2023 Aug; 38(4):406-421. PubMed ID: 36636880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.
    Hanai H; Iida T; Yamada M; Sato Y; Takeuchi K; Tanaka T; Kondo K; Kikuyama M; Maruyama Y; Iwaoka Y; Nakamura A; Hirayama K; Saniabadi AR; Watanabe F
    World J Gastroenterol; 2006 Jun; 12(21):3393-9. PubMed ID: 16733857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte and Monocyte Apheresis for Induction of Remission in Children With New-Onset Inflammatory Bowel Colitis.
    Rolandsdotter H; Eberhardson M; Fagerberg UL; Finkel Y
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):84-89. PubMed ID: 28604509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
    Sakuraba A; Sato T; Morohoshi Y; Matsuoka K; Okamoto S; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
    Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis.
    Chen X; Lou L; Tang H; Tan X; Bi J; Wu H; Li N; Wang Y; Mao J
    J Clin Apher; 2021 Jun; 36(3):454-464. PubMed ID: 33598970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.
    Sakuraba A; Sato T; Naganuma M; Morohoshi Y; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
    J Gastroenterol; 2008; 43(1):51-6. PubMed ID: 18297436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte/Monocyte Adsorptive Apheresis in Moderate to Severe Ulcerative Colitis--Effective or Not?
    Kruis W; Nguyen P; Morgenstern J
    Digestion; 2015; 92(1):39-44. PubMed ID: 26112696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.